Description
FeF® Cetrimide Ph.Eur.
CAS No. 1119-97-7.
It Consists of Trimethyl tetradecyl ammonium bromide. Contains approx. 99% active ingredients.
FeF® Cetrimide is manufactured in accordance with the cGMP Guideline ICH Q7 for Active Pharmaceutical Ingredients and analysed according to the current European Pharmacopoeia (Ph.Eur.).
| Packing sizes | Item no. | Product image |
|---|---|---|
| 25 kg (Double plastic bags in cardboard box) | 7800002 |  |
Documentation and services
Certificate of Suitability (CEP/COS)
European Drug Master File (ASMF)
GMP Certificate (enter Certificate number DK API-H 00073316 and choose Denmark in the country field list)
Certificate of Analysis (current version of pharmacopoeia)
Datasheet
Customer audits
Stability results
Declarations, statements (TSE/BSE, residual solvents, GMO, allergens, animal testing, etc.)
Reach
Change Notification Statement
Pre-filled Supplier Questionnaire
Impurity profile
Description of the manufacturing process
Process flowchart
Packaging details
Quality agreements
Exposure ScenarioDownload pdf
Contact us
Corporate Headquaters
Novo Nordisk Pharmatech A/S
Københavnsvej 216 DK - 4600 Køge
Denmark
Phone: +45 5667 1000
Fax: +45 5667 1001
For complaints or comments about our company or our products, please contact
